NEW YORK (GenomeWeb) – "The proposal we issued a few months ago, is just that. It's a proposal," Jeff Shuren, director of the US Food and Drug Administration's Center for Devices and Radiological Health, said yesterday at the start of a two-day workshop to discuss the agency's draft guidance on regulation of laboratory-developed tests (LDTs). "We do not claim we have gotten everything right."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.